Skip to main content
Caplight Logo









Samphire Neuroscience

Samphire Neuroscience

Private
LondonHealthcare & Life Scienceshttps://www.samphireneuro.com/

Last Round

Seed

Jun 3, 2025

Total Funding Raised

$7.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Samphire Neuroscience is a healthtech company that develops non-invasive, brain-stimulating wearable devices and a companion mobile application to alleviate symptoms associated with the menstrual cycle.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, D2C Brands

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

neuromodulationtDCSwearable medical devicemenstrual healthfemtechnon-invasive brain stimulationneurotechdrug-free pain managementDTC medical devicehealth IoTwellness technologybiohacking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Samphire Neuroscience Comparables

Compare Samphire Neuroscience with similar companies based on industry and business-model similarity.

Samphire Neuroscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Yuthera
88%
Spark Biomedical Inc
83%
Myoovi
83%

Samphire Neuroscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 3, 2025
Pre SeedFeb 21, 2024

Key People

Founding team and executive leadership

Emilė Radytė

Co-Founder, CEO

Founding Team

Ervinas Bern

CTO

Executive Team

Samphire Neuroscience Investors

Notable investors and investment history

Samphire Neuroscience investors
InvestorRounds
Ayuh VenturesSeed, Pre Seed
APEX CapitalSeed
AfterWork VenturesSeed, Pre Seed
InventureSeed
FIRSTPICKSeed, Pre Seed
CVX VenturesPre Seed
Seaside VenturesSeed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 58% MoM.

  • Feb 2, 2026

    Added TechCrunch Media LLC. as a customer.

Samphire Neuroscience Filings

Explore SEC and related filing metadata, where available.

Samphire Neuroscience filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Samphire Neuroscience's valuation, stock price, and market status.

Is Samphire Neuroscience a public or private company?

Samphire Neuroscience is a private company.

What is the current stock price of Samphire Neuroscience?

Samphire Neuroscience is a private company with no public stock price. No recent secondary market data is available.

How much is Samphire Neuroscience worth (valuation)?

Valuation information for Samphire Neuroscience is not publicly available.

Can I buy Samphire Neuroscience stock?

Samphire Neuroscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Samphire Neuroscience's last funding round?

Samphire Neuroscience's most recent funding round was Seed on June 3, 2025.

Who are the main investors in Samphire Neuroscience?

Key investors in Samphire Neuroscience include Inventure, Fortify Ventures.

Will Samphire Neuroscience IPO soon?

No public IPO plans have been announced for Samphire Neuroscience.

How can I track Samphire Neuroscience secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Samphire Neuroscience's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range13
Year Founded2021
Last FundingJun 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?